Asthma is overdiagnosed in an estimated 30% of Canadian adults, according to a study presented at the ATS 2016 International Conference.
A new study has demonstrated a way to deliver a nanoparticle-based gene therapy in order to repair lungs damaged by chronic allergic asthma and to reduce inflammation that causes asthma attacks.
According to a Childhood Asthma Management Program (CAMP) study, persistent childhood asthma may be linked to earlier development of COPD.
Nearly half (48%) of patients with severe or difficult-to-treat asthma in the TENOR II study still had very poorly controlled symptoms after more than a decade of treatment.
A new survey of people living with asthma reveals they may be accepting persistent symptoms and limits to their everyday activities because they believe their asthma is well-controlled.
New data show two-thirds of uncontrolled asthma patients in the US believe their condition is “under control,” suggesting a false sense of confidence in managing their condition.
Patients with early- and late-onset asthma overlapped with COPD showed decreased clinical function and worse overall prognosis in a recent study.
New research suggests that Twitter may help predict and prevent severe asthma attacks in a community.
A Dignity Health study indicates that the use of digital health technology is an effective way to improve asthma control.
A University of Maryland School of Public Health study shows that extreme heat and heavy rainfall are associated with an increased risk of hospitalization for asthma patients in Maryland.
Researchers have identified a biological pathway that may play a direct role in human asthma and airway hyper-responsiveness.
Teva's ProAir RespiClick (albuterol sulfate) Inhalation Powder is approved to treat bronchospasm in children 4 to 11 years of age with asthma and prevent exercise-induced bronchospasm.
As World Asthma Day (May 3) approaches, experts outline the growing problem of asthma and lung diseases as a result of air pollution.
In a recent study, immunotherapy tablets for dust mite allergy reduced the risk of an attack in individuals with moderate to severe asthma.
Blocking a certain signaling molecule can relieve symptoms such as mucus production, swelling, and constriction of the airways in the lungs, a discovery that may potentially improve asthma treatment.
In support of World Asthma Day, May 3, the Forum of International Respiratory Societies (FIRS) is calling for more collaborative action in asthma treatment.
New data indicates that COPD patients who also have asthma are at an increased risk for severe exacerbations.
Northwestern Medicine research shows a new approach to asthma treatment where a nanoparticle acts like a Trojan horse to convince the immune system not to attack it.
Patients with COPD and late-onset asthma have a greater risk of death and hospitalization than early-onset asthma patients with COPD, according to new research.
According to Penn State researchers, people with asthma have identifying molecules circulating in their blood, which is a finding that may lead to the first diagnostic blood test for asthma.